Auphan-Anezin N - Search Results

1

Distinct patterns of cytolytic T-cell activation by different tumour cells revealed by Ca²⁺ signalling and granule mobilization.

Frick M, Mouchacca P, Verdeil G, Hamon Y, Billaudeau C, Buferne M, Fallet M, Auphan-Anezin N, Schmitt-Verhulst AM, Boyer C. Frick M, et al. Among authors: auphan anezin n. Immunology. 2017 Feb;150(2):199-212. doi: 10.1111/imm.12679. Epub 2016 Nov 2. Immunology. 2017. PMID: 27716898 Free PMC article.

2

Distinct thresholds for CD8 T cell activation lead to functional heterogeneity: CD8 T cell priming can occur independently of cell division.

Auphan-Anezin N, Verdeil G, Schmitt-Verhulst AM. Auphan-Anezin N, et al. J Immunol. 2003 Mar 1;170(5):2442-8. doi: 10.4049/jimmunol.170.5.2442. J Immunol. 2003. PMID: 12594268

3

Distinct orientation of the alloreactive monoclonal CD8 T cell activation program by three different peptide/MHC complexes.

Auphan-Anezin N, Mazza C, Guimezanes A, Barrett-Wilt GA, Montero-Julian F, Roussel A, Hunt DF, Malissen B, Schmitt-Verhulst AM. Auphan-Anezin N, et al. Eur J Immunol. 2006 Jul;36(7):1856-66. doi: 10.1002/eji.200635895. Eur J Immunol. 2006. PMID: 16761314 Free article.

4

Temporal cross-talk between TCR and STAT signals for CD8 T cell effector differentiation.

Verdeil G, Chaix J, Schmitt-Verhulst AM, Auphan-Anezin N. Verdeil G, et al. Eur J Immunol. 2006 Dec;36(12):3090-100. doi: 10.1002/eji.200636347. Eur J Immunol. 2006. PMID: 17111352 Free article. Review.

5

CD8 T cell help for innate antitumor immunity.

Shanker A, Verdeil G, Buferne M, Inderberg-Suso EM, Puthier D, Joly F, Nguyen C, Leserman L, Auphan-Anezin N, Schmitt-Verhulst AM. Shanker A, et al. J Immunol. 2007 Nov 15;179(10):6651-62. doi: 10.4049/jimmunol.179.10.6651. J Immunol. 2007. PMID: 17982055

6

Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling.

Grange M, Verdeil G, Arnoux F, Griffon A, Spicuglia S, Maurizio J, Buferne M, Schmitt-Verhulst AM, Auphan-Anezin N. Grange M, et al. J Immunol. 2013 Oct 1;191(7):3712-24. doi: 10.4049/jimmunol.1300319. Epub 2013 Sep 4. J Immunol. 2013. PMID: 24006458

7

Silence STAT3 in the procancer niche… and activate CD8+ T cells to kill premetastatic myeloid intruders.

Auphan-Anezin N, Schmitt-Verhulst AM. Auphan-Anezin N, et al. Eur J Immunol. 2015 Jan;45(1):44-8. doi: 10.1002/eji.201445300. Eur J Immunol. 2015. PMID: 25471823 Free article.

8

Differential survival of transferred CD8 T cells and host reconstitution depending on TCR avidity for host-expressed alloantigen.

Auphan-Anezin N, Schmitt-Verhulst AM. Auphan-Anezin N, et al. J Immunol. 2001 Jun 15;166(12):7200-7. doi: 10.4049/jimmunol.166.12.7200. J Immunol. 2001. PMID: 11390468

9

Gene profiling approach to establish the molecular bases for partial versus full activation of naïve CD8 T lymphocytes.

Verdeil G, Puthier D, Nguyen C, Schmitt-Verhulst AM, Auphan-Anezin N. Verdeil G, et al. Ann N Y Acad Sci. 2002 Dec;975:68-76. doi: 10.1111/j.1749-6632.2002.tb05942.x. Ann N Y Acad Sci. 2002. PMID: 12538155

10

Thymocyte-intrinsic genetic factors influence CD8 T cell lineage commitment and affect selection of a tumor-reactive TCR.

Shanker A, Auphan-Anezin N, Chomez P, Giraudo L, Van den Eynde B, Schmitt-Verhulst AM. Shanker A, et al. J Immunol. 2004 Apr 15;172(8):5069-77. doi: 10.4049/jimmunol.172.8.5069. J Immunol. 2004. PMID: 15067090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters